Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON44284
NL-OMON44284
Recruiting
Not Applicable

Atherosclerosis and the Innate immune system in patients with Diabetes - AID

Academisch Medisch Centrum0 sites640 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsarterial wall thickeningatherosclerosis1001842410003216

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
arterial wall thickening
Sponsor
Academisch Medisch Centrum
Enrollment
640
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Aged 18 years or older
  • •\- Diagnosed with diabetes mellitus type 2 ;Control subjects
  • •\- Age 18 years or older
  • •\- No history of diabetes mellitus or impaired glucose tolerance
  • •\- No history of cardiovascular events
  • •\- No medication use

Exclusion Criteria

  • •Exclusion criteria for all subjects
  • •\- Known malignant disorders or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
  • •\- Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.
  • •\- History of cardiovascular event within the last 3 months.
  • •\- Clinical signs of acute infection and/or CRP \> 10 mg/L.
  • •\- The use of chronic immunosuppressant drugs or antibiotics in the last 6 weeks.
  • •\- Chronic use of anti\-inflammatory drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The Innate Immune System in Atherosclerosisarterial wall thickeningatherosclerosis100126531000381610003216
NL-OMON40196Academisch Medisch Centrum240
Completed
Not Applicable
The innate immune system in atherosclerosis - IIarterial wall thickeningatherosclerosis10003216
NL-OMON42376Academisch Medisch Centrum340
Active, not recruiting
Not Applicable
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesSystemic Lupus Erythematosus
NCT04276701University Hospital, Bordeaux500
Unknown
Not Applicable
Investigating Atherosclerosis In Seronegative SpondyloarthropathyIn Seronegative Spondyloarthropathy
NCT04891783Sohag University120
Completed
Not Applicable
Vascular Inflammation Stratified by Body Size PhenotypeAtherosclerosisObesityMetabolic Syndrome
NCT01979068Korea University250